Background {#Sec1}
==========

The number of prosthetic orthopaedic implants has increased, and the frequency of infections that can be attributed to these prostheses is a real public health problem \[[@CR1]\]. Prosthetic joint infections typically result from infections with aerobic bacteria such as Staphylococci, Streptococci*,* Enterococci and Gram-negative bacilli \[[@CR1]\].

Zoonotic prosthetic joint infections have been reported in previous studies such as prosthetic joint infection caused by *Brucella* sp. \[[@CR2]\], *Salmonella sp*. \[[@CR3]\], and *Campylobacter sp*. \[[@CR4]\]. A recent case of hip prosthetic infection due to *Streptococcus suis* has been reported in a 74-year-old male American farmer with a history of non-Hodgkin's lymphoma \[[@CR5]\].

*Pasteurella multocida* is a Gram-negative nonmotile coccobacillus found worldwide. It can be found in the nasopharynx or gastrointestinal tract of wild animals, cats and dogs \[[@CR6]\]. Human infections with *P. multocida* are most often the result of direct tissue inoculation and usually take the form of an acute local cellulitis, tenosynovitis or osteomyelitis. Septicaemia, meningitis, peritonitis and pneumonia have also been reported \[[@CR7]\].

Prosthetic joint infection due to *P. multocida* is rare, as only 26 cases have been reported in the literature to date. These prosthetic joint infections due to *P. multocida* were associated with the same comorbidities as for other prosthetic joint infections \[[@CR8]\] and precession by a cat or dog bite, scratching or licking distal to the affected joint \[[@CR9]\]. The aim of this study was to review all the cases of prosthetic joint infection caused by *P. multocida* among the cases of prosthetic joint infection managed in a referral centre for the treatment of bone and joint infections (CRIOA) in southern France.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

We retrospectively reviewed all cases of prosthetic joint infection caused by *P. multocida* among the 4686 cases of prosthetic joint infection in 14,200 patients (inpatients and outpatients \>18 years) managed for bone and joint infection from January 1993 to December 2013. This study was approved by the institutional research ethics board and a written informed consent was signed by each patient. All cases were managed at the inter-regional referral centre for the treatment of bone and joint infection in southern France, grouping together four University Hospitals and a military teaching hospital with a total of 4000 beds in Marseille, France, where a local population of approximately 852,516 was recorded in January 2012.

All episodes of prosthetic joint infection caused by *P. multocida* were diagnosed based on past medical history with clinical evidence of infection using biological and/or radiological compliant data, with at least one positive culture of *P. multocida* identified from ≥ 2 deep samples based on a surgical procedure that excluded bacterial contamination. Infections involving a prosthetic joint were classified according the time of onset after implantation: early infection within a month or chronic infections after 1 month \[[@CR10]\]. We recorded the medical history, assessing factors such as the demographic characteristics of patients, and risk factors associated with *Pasteurella* prosthetic joint infection, including medical history of animal bites or scratches, cancer, haematological malignancy, systemic or local corticosteroid treatment, diabetes mellitus and alcoholism. We also recorded the location of the *Pasteurella* prosthetic joint infection. We individually reviewed the antibiotic treatment and/or surgical treatment approach used. The clinical outcome was evaluated at 1, 3, 6, 12 and 24 months after the end of antibiotic treatment.

Specimen collection and microbiological analysis {#Sec4}
------------------------------------------------

Deep samples obtained by surgical procedures, i.e., joint fluids, crushed tissue or bone biopsies, were inoculated on 5 % sheep blood, chocolate, Mueller-Hinton, trypticase soy and MacConkey agar plates (BioMérieux, France) and incubated at 37 °C in a 5 % CO2 atmosphere and in an anaerobic atmosphere for 10 days. For mycobacterial culture we inoculated the samples in the MGIT tubes (Becton Dickinson, Pont-De-Claix, France) or on a home-made 5 % sheep blood agar (BioMérieux, La Balme-les-Grottes, France) for 2--45 days at 32 °C or 37 °C as previously described \[[@CR11], [@CR12]\]. Pure bacterial cultures, obtained by picking isolated colonies, were identified with semi-automated Gram staining (Aerospray Wiescor, Elitech), catalase and oxidase activity tests, and the Vitek 2 system (BioMérieux, Marcy l'Etoile, France). The antibiotic susceptibility of *P. multocida* isolates were determined and interpreted according to the recommendations of the French Society for Microbiology (<http://www.sfm-microbiologie.org/UserFiles/files/casfm/CASFM_EUCAST_V1_0_2014.pdf>).

Results {#Sec5}
=======

We have identified six cases of prosthetic joint infection caused by *P. multocida* among the 4686 cases of prosthetic joint infection managed in our centres over the last 20 years. The mean age of our cases was 74 years \[±8.2, range 63--85\]. A medical history of cat scratches was identified in two cases, dog licks on surgical wound in few days before the beginning of symptoms in two cases and close-contact with cats or dogs in two cases. In two cases occurred after dog lick, culture from the dog's mouth cavities also yielded *P. multocida*. Two of our cases had diabetic mellitus and there was one case of class III obesity (body mass index at 55). One of our cases developed breast cancer 4 years after the prosthetic joint infection.

Five of our cases were associated with knee prostheses (Fig. [1](#Fig1){ref-type="fig"}) and one case with a hip prosthesis. Mean time delay between prosthetic joint implantation and infection onset was 7.6 years (±5.12 years, range 2--17). Local inflammation, which occurred in all six cases, was the most frequent clinical symptom, followed by pain in five cases, fever and swollen joints in four cases, and a fistula with purulent discharge inside the wound in two cases. Delay between first infectious signs and diagnosis of prosthetic joint infection was poorly reported in literature. Prosthesis loosening was observed in two cases including one case before infection and one case related to infection. None of the cases had positive blood culture of *P. multocida*.Fig. 1Frontal radiograph of the left knee at admission demonstrates normal post-operative appearance of prosthesis with no prosthetic loosening (**a**); Computer tomography (CT) shows an abscess in front of the knee prosthesis caused by *Pasteurella multocida* (**b** and **c**)

Diagnoses of prosthetic joint infection caused by *P. multocida* were made by the positive culture of the percutaneous needle aspiration of articular fluid in two cases, and surgical deep samples in four cases. Surgical treatment was performed in six cases, including surgical lavage and debridement and prosthesis retention in three cases and prosthesis removal in three cases. All six cases received a combination of antibiotic treatment with amoxicillin and doxycycline. The mean time of antibiotic treatment was 8 months, range 6--18 months.

Six of our cases were in remission without apparent relapse at 3 years after end of treatment. One case was infected with *S. enteritidis* at 3 years after end of treatment on the same prosthesis.

Discussion {#Sec6}
==========

We reported six cases of prosthetic joint infection caused by *P. multocida* managed in our centers over the last 20 years. The rate of prosthetic joint infection caused by *P. multocida* is low, representing thus only 0.1 % of all cases of prosthetic joint infection in our experience. To our knowledge, only 26 cases of prosthetic joint infection caused by *P. multocida* have been reported in the literature \[[@CR13]--[@CR35]\]. The mean age of cases reported was 67 years (±9.6 years, range 33--88 years). Prosthetic joint infections caused by *P. multocida* were usually a contiguous infection after scratching, biting or licking feet and more frequently localized in the knee than in the hip (21 cases vs. 5 cases) (Table [1](#Tab1){ref-type="table"}). Haematogenous prosthetic joint infections caused by *P. multocida* were rarely reported and usually affected more than one prosthesis, such as two cases where both knee prostheses were infected after haematogenous dissemination \[[@CR20], [@CR21]\].Table 1Clinical characteristics and treatment of the 32 cases of prosthetic joint infection due to Pasteurella multocida including six cases in our study and the 26 cases reported in literatureStudiesReferencesSexAge (years)SitesContacts with animalComorbiditiesMedical treatmentSurgical treatmentOutcomeThis reportMale65KneeDog licksNoneAmoxicillin, doxycyclineSurgical lavage and debridementCureThis reportMale82HipCat scratchesNoneAmoxicillin, doxycyclineSurgical lavage and debridementCureThis reportFemale63KneeCat scratchesDiabetes mellitusAmoxicillin, doxycyclineReplacement of prosthesis (two-stage exchange strategy)CureThis reportMale65KneeDog licksDiabetes mellitus, Foot ulcerationAmoxicillin, doxycyclineReplacement of prosthesis (two-stage exchange strategy)CureThis reportFemale81KneeCat contactsObesity (BMC at 55)Amoxicillin, doxycyclineReplacement of prosthesis (two-stage exchange strategy)CureThis reportFemale85KneeCat and dog contactsNoneAmoxicillin, doxycyclineSurgical lavage and debridementCureFerguson et al. (2014)\[[@CR13]\]Female67KneeDog licksNoneLinezolid and ciprofloxacinSurgical lavage and debridementCureRomanò et al. (2013)\[[@CR35]\]Female82KneeCat scratchesRheumatoid arthritisAmoxicillin-clavulanic acid, ciprofloxacinSurgical lavage and debridementCureHeydemann, Heydemann, and Antony (2010)\[[@CR34]\]Male66KneeCat scratchesNoneAmpicillin/sulbactamRemoval of tibia insertCureKadakia and Langkamer (2008)\[[@CR33]\]Female80KneeCat bitesBreast carcinomaCefuroximeSurgical lavage and debridementCureHeym et al. (2006)\[[@CR32]\]Female72KneeDog licksNoneAmoxicillin, doxycycline, ciprofloxacin, rifampinReplacement of prosthesis (two-stage exchange strategy)CureMehta and Mackie (2004)\[[@CR30]\]Female84HipCat scratchesRheumatoid arthritisBenzyl penicillin, ciprofloxacinReplacement of prosthesis (two-stage exchange strategy)CureMehta and Mackie (2004)\[[@CR30]\]Female57HipCat scratchesRheumatoid arthritisFlucloxacillin, benzyl penicillinReplacement of prosthesis (two-stage exchange strategy)CureStiehl, Sterkin, and Brummitt (2004)\[[@CR29]\]Male63KneeHorse injuryNoneCiprofloxacin, piperacillin/tazobactamReplacement of prosthesis (two-stage exchange strategy)CurePolzhofer, Hassenpflug, and Petersen (2004)\[[@CR31]\]Female73KneeCat bitesNoneAmpicillin/sulbactam, clindamycinSurgical lavage and debridementCureCiampolini, Timperley, and Morgan (2004)\[[@CR37]\]Female73KneeCat scratchesNoneBenzyl penicillin, ciprofloxacinReplacement of prosthesis (two-stage exchange strategy)CureChikwe et al. (2000)\[[@CR28]\]Male69HipDog contactsNoneInformation is not availableReplacement of prosthesis (two-stage exchange strategy)CureMaradona et al. (1997)\[[@CR27]\]Female73KneeDog bitesDiabetes mellitusPenicillin, ciprofloxacinSurgical lavage and debridementCureTakwale et al. (1997)\[[@CR26]\]Female57HipCat scratchesRheumatoid arthritisFlucloxacillin, benzyl penicillin, metronidazole, ciprofloxacinReplacement of prosthesis (two-stage exchange strategy)CureAntuña et al. (1997)\[[@CR25]\]Female73KneeDog bitesRheumatoid arthritisCiprofloxacinSurgical lavage and debridementCureGabuzda and Barnett (1992)\[[@CR22]\]Female88KneeCat bitesNonePenicillinReplacement of prosthesis (two-stage exchange strategy)CureGuion and Sculco (1992)\[[@CR23]\]Female45KneeDog scratchesRheumatoid arthritisCefotaximeReplacement of prosthesis (two-stage exchange strategy)CureBraithwaite and Giddins (1992)\[[@CR24]\]Female48HipCat bitesDiabetes mellitusPenicillin, FlucloxacillinReplacement of prosthesis (two-stage exchange strategy)CureTaillan et al. (1988)\[[@CR38]\]Female79KneeCat bitesRheumatoid arthritis, Acute leukemiaPefloxacinNoneCureOrton and Fulcher (1984)\[[@CR21]\]Female74Knee (both)Cat bitesNoneAmpicillin, penicillin, doxycyclineReplacement of prosthesis (two-stage exchange strategy)CureMellors and Schoen (1985)\[[@CR20]\]Female62Knee (both)Cat scratchesNonePenicillinNoneCureGomez-Reino et al. (1980)\[[@CR19]\]Female64KneeCat bitesNoneCephalothinReplacement of prosthesis (two-stage exchange strategy)CureSpagnuolo (1978)\[[@CR18]\]Female72KneeCat bitesNonePenicillinSurgical lavage and debridementCureArvan and Goldberg (1978)\[[@CR17]\]Female72KneeCat bitesNonePenicillinSurgical lavage and debridementCureSugarman, Quismorio, and Patzakis (1975)\[[@CR16]\]Female33KneeDog licksRheumatoid arthritisCloxacillin, penicillinReplacement of prosthesis (two-stage exchange strategy)CureGriffin and Barber (1975)\[[@CR14]\]Female64KneeCat scratchesRheumatoid arthritisAmpicillinNoneCureMaurer, Hasselbacher, and Schumacher (1975)\[[@CR15]\]Female55KneeDog licksRheumatoid arthritisPenicillinNoneCure

Most of the cases in the literature occurred after animal bites or scratches, including 17 cases (65 %) after cat bites or scratches and eight cases (31 %) after dog scratches, bites, or licks and one case after a horse bite. Most of our cases involve animal contact or bites, consistent with the zoonotic origin of *Pasteurella multocida*.

Forty-two percent of the reported cases of prosthetic joint infection due to *P. multocida* presented at least one comorbidity. In general, diabetes mellitus appears to be a main comorbidity associated with prosthetic joint infections, but this underlying condition was identified in four cases only among the 32 reported cases (2 cases in the literature and 2 in this cases series). The major comorbidity related to prosthetic joint infection caused by *P. multocida* was rheumatoid arthritis treated with immunosuppressive drugs, which was observed in ten reported cases (38 %). None of our patients had rheumatoid arthritis and none was treated with immunosuppressive drugs, this observation illustrating that this factor is not perhaps as important as it might otherwise seem for prosthetic joint infection due to *P. multocida*.

Other uncommon comorbidities such as solid cancers have been observed in few reported cases, including one case of leukaemia and one case of breast carcinoma. None of our patients has a medical history of cancer during the management of prosthetic joint infections caused by *P. multocida*, but one of our patients developed breast cancer within 4 years after her prosthetic joint infection. Immunodeficiency should be considered a risk factor or comorbidity of prosthetic joint infection caused by *P. multocida,* especially in case of recurrence.

Prosthetic joint infections caused by *P. multocida* are monomicrobial infections and are sensitive to penicillin and doxycycline. Prosthesis removal remains a main treatment option in the cases reported in literature (14 cases; 54 %) followed by surgical debridement with prosthesis retention (8 cases; 31 %) and antibiotic treatment without surgery (4 cases; 15 %). The remission rate is high (85 %); only four reported cases treated initially with surgical debridement were subsequently treated with prosthesis removal \[[@CR16], [@CR19], [@CR21], [@CR32]\]. Three of the four cases had arthritis, one case was bacteremic to *P. multocida*, and he had a prosthetic joint infection due to *P. multocida* and *Pseudomonas aeruginosa*. We didn't found any microbiologic information concerning the failure after medical treatment \[[@CR21]\]. One case had first medical treatment 6 weeks and no surgical debridement \[[@CR19]\]. One case had a cemented total knee arthroplasty with unchanged polyethylene tibial insert \[[@CR32]\] (Table [1](#Tab1){ref-type="table"}).

*P. multocida* appears to be a nonmotile coccobacillus recovered from the nasopharynx or gastrointestinal tract of wild animals, cats and dogs \[[@CR6]\]. *P. multocida* are most often the result of direct tissue inoculation. We can assume that infections are locally contiguous and similar to the acute haematogenous prosthetic joint infection, surgical lavage, debridement and prosthesis retention associated with prolonged antimicrobial treatment should have a high success rate, which is the case in the literature and in our three cases.

*P. multocida* is known as a virulent pathogen, which has the ability to produce an in vitro biofilm \[[@CR36]\]. Nevertheless, the case of *P. multocida* prosthetic joint infection can be caused by no-biofilm producer isolate \[[@CR35]\]. We believe that increasing the studies on the biofilm role of *P. multocida* isolates in prosthetic joint infection should enable a better understanding of the pathogenesis of this bacterium and a better definition of treatment strategies. According to our findings and literature review, we believe that surgical lavage, debridement and prosthesis retention combined with prolonged antibiotic treatment is sufficient for the treatment of prosthetic joint infection caused by *P. multocida*.

Generally it is recommended that patients with animal bites receive systematic antibiotics to prevent infections due to *P. multocida* and other pathogens that form part of the oral animal flora \[[@CR9]\]. Animal bites or scratches or licks from pets are a possibility in people with arthroplasty, particularly in the elderly, we think that they should be told of the risks and the action to be taken if it happens. Based on our review, we suggest that patients with orthopedic devices who have been bitten or scratched by animals should be early treated with either penicillin or doxycycline to avoid systemic spread and infection of the prosthesis with *P. multocida*.

Conclusion {#Sec7}
==========

Prosthetic joint infections caused by *P. multocida* are rare and most commonly follow animal scratches or bites, but can occasionally occur after a short animal lick. Prosthetic joint infections caused by *P. multocida* were usually localized in the knee resulting from a contiguous infection, but haematogenous dissemination can occasionally affect more than one prosthesis. As there is no clear evidence that *P. multocida* could generate biofilm, we believe that early antibiotic therapy after surgical debridement could avoid prosthetic withdrawal, notably in elderly patients. However, early treatment after dog or cat scratch, bites or lick in a patient with joint prosthesis may be prevent prosthetic joint infection due to *Pasteurella multocida*.
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